INTERRUPTION OF GESTATION IN A BITCH USING A COMBINED TREATMENT OF CLOPROSTENOL AND CABERGOLINE
Descripción del Articulo
The effectiveness of a combined treatment of cloprostenol and cabergoline was evaluated for interruption of gestation in bitches. A clinical experience is reported in an English bulldog bitch with a gestation of 30 days. The treatment was administrated every 24 hours and consisted in 5 μg/kg of cabe...
Autores: | , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2010 |
Institución: | Universidad Nacional Mayor de San Marcos |
Repositorio: | Revistas - Universidad Nacional Mayor de San Marcos |
Lenguaje: | español |
OAI Identifier: | oai:ojs.csi.unmsm:article/477 |
Enlace del recurso: | https://revistasinvestigacion.unmsm.edu.pe/index.php/veterinaria/article/view/477 |
Nivel de acceso: | acceso abierto |
Materia: | Perra interrupción de preñez cloprostenol cabergolina bitch termination of pregnancy cabergoline |
Sumario: | The effectiveness of a combined treatment of cloprostenol and cabergoline was evaluated for interruption of gestation in bitches. A clinical experience is reported in an English bulldog bitch with a gestation of 30 days. The treatment was administrated every 24 hours and consisted in 5 μg/kg of cabergoline, orally, followed 30 minutes later by 1 μg/kg of cloprostenol, via subcutaneous. Physiological constants, effects post administration, and ecographic evolution of the gestation was evaluated. Also, progesterone concentration was determined in two blood samples using a quantitative commercial kit. Changes in gestational vesicles were observed at day 3 of treatment, and a lower cardiac frequency (<180 bpm) were recorded on day 4. A fetal expulsion occurred few hours later. Ultrasound on day 5 showed absence of vesicles and fetuses. Serum progesterone concentration on day 3 was 1 to 2.5 ng/ml, incompatible with the maintenance of gestation, and on day 5 was <1 ng/ml. The results allowed confirming the effectiveness of this protocol to interrupt gestations in bitches, highlighting the short duration of the treatment (4 days). |
---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).